N07.5 Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis

Name of the Condition

• Hereditary Nephropathy, Not Elsewhere Classified with Diffuse Mesangiocapillary Glomerulonephritis
• ICD-10 Code: N07.5

Summary

Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis, is a genetic kidney disorder characterized by inherited diffuse mesangiocapillary glomerulonephritis (MCGN), a type of glomerular disease involving thickening of the glomerular basement membrane and mesangial expansion. This condition leads to progressive kidney damage, often presenting with proteinuria, hematuria, and reduced renal function. Management focuses on slowing disease progression and addressing complications.

Causes

This condition results from genetic mutations affecting kidney structure or function, typically inherited in an autosomal dominant or recessive pattern. The mutations disrupt normal glomerular filtration, leading to the characteristic diffuse mesangiocapillary changes. While specific genetic defects may vary, the hereditary nature is a key diagnostic feature, and some cases may have unidentified genetic causes.

Risk Factors

• Family history of kidney disease: A genetic predisposition increases risk.
• Inherited genetic mutations: Specific gene variants associated with glomerular abnormalities.
• Consanguinity: Higher likelihood of recessive disorders in closely related families.

Symptoms

• Hematuria (blood in urine, visible or microscopic).
• Proteinuria (excess protein in urine, potentially causing foamy urine).
• Reduced kidney function, which may be asymptomatic initially.
• Edema (swelling) due to protein loss or fluid retention.
• Hypertension (high blood pressure) as kidney function declines.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urinalysis may show hematuria or proteinuria. Blood tests assess kidney function (e.g., creatinine, eGFR). Kidney biopsy is often performed to confirm diffuse mesangiocapillary glomerulonephritis and rule out other causes. Genetic testing may identify underlying mutations, though this is not always available or conclusive.

Treatment Options

Treatment aims to slow disease progression and manage symptoms. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may reduce proteinuria and blood pressure. Immunosuppressive therapies (e.g., corticosteroids, cytotoxic agents) are sometimes used, though evidence for hereditary MCGN is limited. Dialysis or kidney transplantation may be necessary in advanced cases.

Prognosis and Follow-Up

Prognosis varies depending on disease severity and response to treatment. Progressive kidney damage is common, and some patients may develop end-stage renal disease (ESRD) requiring dialysis or transplantation. Regular monitoring of kidney function, blood pressure, and proteinuria is essential. Follow-up care includes ongoing management of complications and adjustments to treatment as needed.

Complications

• End-stage renal disease (ESRD): Severe kidney failure requiring dialysis or transplantation.
• Hypertension: Persistent high blood pressure, which can worsen kidney damage.
• Nephrotic syndrome: Severe protein loss leading to edema and other systemic effects.
• Infections: Increased risk due to impaired immune function or treatment side effects.

Lifestyle & Prevention

• Blood pressure control: Maintain healthy blood pressure through diet, exercise, and medication.
• Dietary management: Limit sodium and protein intake as advised by a healthcare provider.
• Avoid nephrotoxins: Refrain from medications or substances that may harm the kidneys.
• Regular monitoring: Follow up with a nephrologist to track kidney function and adjust care.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, foamy urine, unexplained swelling, or symptoms of kidney failure (e.g., fatigue, nausea, reduced urine output). Early evaluation is critical to slow disease progression and manage complications.

Tips for Medical Coders

Document the presence of diffuse mesangiocapillary glomerulonephritis and its hereditary nature to support the N07.5 code. Include details on biopsy findings, genetic testing results (if available), and clinical manifestations (e.g., proteinuria, hematuria) to ensure accurate coding. Verify that the condition is not classified under a more specific code and that documentation aligns with the ICD-10-CM guidelines for hereditary nephropathies.